| Product Code: ETC8276189 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Continuous Subcutaneous Insulin Infusion Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Continuous Subcutaneous Insulin Infusion Market - Industry Life Cycle |
3.4 Mexico Continuous Subcutaneous Insulin Infusion Market - Porter's Five Forces |
3.5 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.7 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Mexico Continuous Subcutaneous Insulin Infusion Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Mexico |
4.2.2 Growing awareness about the benefits of continuous subcutaneous insulin infusion therapy |
4.2.3 Technological advancements in insulin infusion devices |
4.3 Market Restraints |
4.3.1 High cost associated with continuous subcutaneous insulin infusion therapy |
4.3.2 Limited reimbursement options for patients |
4.3.3 Regulatory challenges in the medical device industry in Mexico |
5 Mexico Continuous Subcutaneous Insulin Infusion Market Trends |
6 Mexico Continuous Subcutaneous Insulin Infusion Market, By Types |
6.1 Mexico Continuous Subcutaneous Insulin Infusion Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Tethered, 2021- 2031F |
6.1.4 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Patch, 2021- 2031F |
6.2 Mexico Continuous Subcutaneous Insulin Infusion Market, By End Use |
6.2.1 Overview and Analysis |
6.2.2 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3 Mexico Continuous Subcutaneous Insulin Infusion Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 1 diabetes, 2021- 2031F |
6.3.3 Mexico Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 2 diabetes, 2021- 2031F |
7 Mexico Continuous Subcutaneous Insulin Infusion Market Import-Export Trade Statistics |
7.1 Mexico Continuous Subcutaneous Insulin Infusion Market Export to Major Countries |
7.2 Mexico Continuous Subcutaneous Insulin Infusion Market Imports from Major Countries |
8 Mexico Continuous Subcutaneous Insulin Infusion Market Key Performance Indicators |
8.1 Patient adherence rate to continuous subcutaneous insulin infusion therapy |
8.2 Average time taken for patients to achieve glycemic control with insulin infusion therapy |
8.3 Number of healthcare providers trained in administering and managing continuous subcutaneous insulin infusion therapy |
9 Mexico Continuous Subcutaneous Insulin Infusion Market - Opportunity Assessment |
9.1 Mexico Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Mexico Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.3 Mexico Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 Mexico Continuous Subcutaneous Insulin Infusion Market - Competitive Landscape |
10.1 Mexico Continuous Subcutaneous Insulin Infusion Market Revenue Share, By Companies, 2024 |
10.2 Mexico Continuous Subcutaneous Insulin Infusion Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here